Principal Investigator
David Kerman
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20251061
Clinical Trial Summary
Sanofi-Aventis-EFC18326-A multicenter, multinational, randomized, double-blind, Placebo-controlled Phase 3, induction study to evaluate
the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s Disease.
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu